粒细胞集落刺激因子对于血管紧张素Ⅱ所致小鼠心室肥厚的保护作用

Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Mice Cardiac Hypertrophy Induced by Angiotensin Ⅱ

  • 摘要: 背景以往研究表明粒细胞集落刺激因子(G-CSF)对于心肌梗死和阿霉素所致心肌病的心功能不全有改善作用。目的研究 G-CSF 对于血管紧张素Ⅱ(AngⅡ)所致心室肥厚过程中心室重塑的作用。方法雄性野生型(WT)小鼠36只随机分为4组:空白对照组(n=9),或小鼠皮下注射G-CSF(10μg/kg,n=9),或给药 AngⅡ(2.88 mg/kg,n=9),或给药 Ang Ⅱ同时皮下注射 G-CSF(Ang Ⅱ 2.88 mg/kg+G-CSF 10μg/kg,n=9)。测量各组小鼠的血压和心功能。处死动物后测量心室质量/体质量,心肌细胞横截面积和纤维化面积。采用 RT-PCR的方法检测心肌组织中骨桥蛋白的 mRNA 表达量。采用 Western-Blot 的方法检测心肌组织中血管紧张素转换酶(ACE),ACE2和磷酸化 p70S6激酶蛋白的表达量。结果 Ang Ⅱ使 WT 小鼠血压显著升高收缩压,Ang Ⅱ给药组:(139.7±1.6)mmHg 比 WT 组:(108.7±2.3)mmHg,P<0.05并出现心室肥大和纤维化。G-CSF 不影响血压,却明显减少了心肌细胞横截面积AngⅡ+G-CSF 组:(181.06±0.11)比 AngⅡ给药组:(202.02±0.16)μm2,P<0.05、纤维化面积Ang Ⅱ+G-CSF 组:(2.87±0.12)%比 AngⅡ给药组:(3.91±0.06)%,p<0.05、心室质量体质量比Ang Ⅱ+G-CSF 组:(3.7±0.2)mg/g 比 Ang Ⅱ给药组:(4.2±0.1)mg/g,P<0.05,以及左心室舒张功能等容舒张时间,Ang Ⅱ+G-CSF 组:(0.11±0.02)ms 比 Ang Ⅱ给药组:(0.16±0.01)ms,P<0.05。Western-Blot 和 RT-PCR 的结果表明 G-CSF 降低了 ACE、骨桥蛋白、磷酸化 p70S6激酶的表达量,同时增加了ACE2的表达量。结论这些结果说明 G-CSF 能够防止 Ang Ⅱ所致心室肥厚。G-CSF 治疗增加 ACE2的表达量,抑制了 Ang Ⅱ引起心室肥厚。抑制 OPN 表达和 p70S6K 磷酸化,这些因素可能介导了 G-CSF 抑制心室肥厚、改善心室重塑的治疗作用。

     

    Abstract: Background Granulocyte colony-stimulating factor(G-CSF)has been reported to have beneficial effect on cardiac dysfunction in post infarction and doxorubicin-induced cardiomyopathy.Objective To investigate the effects of G-CSF on cardiac remodeling in cardiac hypertrophy induced by angiotensin Ⅱ(Ang Ⅱ).Methods Thirty-six male wild type mice(WT)were allocated randomly to receive subcutaneously G-CSF(10 μg/kg per day, n=9),or Ang Ⅱ(2.88 mg/kg per day,n=9),or Ang Ⅱ plus G-CSF(Ang Ⅱ 2.88 mg/kg+G-CSF 10 μg/kg,n =9)for 4 weeks with untreated WT(n=9)as controls.Blood pressure and cardiac function were measured. Heart weight/body weight ratio,myocyte cross-sectional area and fibrosis area were determined.The mRNA ex- pression of osteopontin(OPN)in myocardium was detected by RT-PCR.The expressions of angiotensin converting enzyme(ACE),ACE2 and phosph-p70S6 kinase protein in myocardium were assessed by Western-Blot.Results Ang Ⅱ significantly elevated blood pressure(SBP,Ang Ⅱ:139.7±1.6 vs WT:108.7±2.3 mmHg,P<0.05) and caused cardiac hypertrophy and fibrosis.G-CSF treatment did not prevent the Ang Ⅱ-induced elevation of blood pressure(SBP,Ang Ⅱ+G-CSF:140.1±2.6 vs Ang Ⅱ:139.7±1.6 mmHg,P>0.05),but significantly attenuated the myocyte cross-sectional area(Ang Ⅱ+G-CSF:181.06±0.11 vs Ang Ⅱ:202.02±0.16 μm~2,P< 0.05),fibrosis area(Ang Ⅱ+G-CSF:2.87%±0.12% vs Ang Ⅱ:3.91%±0.06%,P<0.05),heart weight/ body weight ratio(Ang Ⅱ+G-CSF;3.7±0.2 vs Ang Ⅱ:4.2±0.1 mg/g,P<0.05),and left ventricular diastolic function(cardiac isovolumic relaxation time,Ang Ⅱ+G-CSF:0.11±0.02 vs Ang Ⅱ:0.16±0.01 ms,P<0.05). Further more,G-CSF reduced cardiac levels of ACE,OPN,phosph-p70S6 kinase and increased the expression of ACE2.Conclusion These data suggest that G-CSF reduces Ang Ⅱ induced hypertrophy.The effect of G-CSF on the prevention of cardiac fibrosis and hypertrophy was associated with the inhibition of OPN and phosph-p70S6 ki- nase expression.

     

/

返回文章
返回